The FDA announced on December 19, 2023, that OriGen Biomedical, Inc. is recalling accessory set syringes because they contain syringes not yet qualified for the intended purpose. The firm initiated this voluntary Class II recall due to design changes and material issues affecting gamma sterilization.
How to tell if you have it
- Brand: OriGen
- Product: Accessory Sets Syringes
- 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15
- 60ml syringe on a female luer with 15cm sealed SCD tubing, REF: 15-RF60-T
- REF/UDI-DI/Lots: RF-T15/10816203020205/V23277, V23278, V23639
- REF/UDI-DI/Lots: 15-RF60-T/10816203020571/V23281
- Quantity: 3613 Cases
The hazard
The accessory sets contain syringes that were gamma sterilized but resulted in yellowed syringes due to design changes to the syringe barrels and a polypropylene resin change that caused a loss of gamma compatibility. The FDA stated these syringes are not yet qualified for the accessory's intended purpose.
Context
GovInfoNow's records show OriGen Biomedical, Inc. has had five other recalls since August 2, 2017, including an Evolve Cell Culture Bag recall on January 28, 2021, for incorrect phthalate labeling. Other recent recalls of similar products include Medline's February 27, 2026, recall of 10mL Polycarbonate Syringes and Convenience Kits with colored or unapproved syringes due to unapproved design changes.